Reversal of bone loss in mice by nongenotropic signaling of sex steroids

被引:332
作者
Kousteni, S
Chen, JR
Bellido, T
Han, L
Ali, AA
O'Brien, CA
Plotkin, L
Fu, Q
Mancino, AT
Wen, Y
Vertino, AM
Powers, CC
Stewart, SA
Ebert, R
Parfitt, AM
Weinstein, RS
Jilka, RL
Manolagas, SC [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[4] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[5] Univ Arkansas Med Sci, Div Biometry, Little Rock, AR 72205 USA
[6] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA
关键词
D O I
10.1126/science.1074935
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We show that sex steroids protect the adult murine skeleton through a mechanism that is distinct from that used to preserve the mass and function of reproductive organs. The classical genotropic actions of sex steroid receptors are dispensable for their bone protective effects, but essential for their effects on reproductive tissues. A synthetic ligand (4-estren-3alpha, 17beta-diol) that reproduces the nongenotropic effects of sex steroids, without affecting classical transcription, increases bone mass and strength in ovariectomized females above the level of the estrogen-replete state and is at least as effective as dihydrotestosterone in orchidectomized males, without affecting reproductive organs. Such ligands merit investigation as potential therapeutic alternatives to hormone replacement for osteoporosis of bone mass in both women and men.
引用
收藏
页码:843 / 846
页数:5
相关论文
共 21 条
[1]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[2]   Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen [J].
Chen, Z ;
Yuhanna, IS ;
Galcheva-Gargova, Z ;
Karas, RH ;
Mendelsohn, RE ;
Shaul, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :401-406
[3]   Mechanisms of estrogen receptor action in the myocardium -: Rapid gene activation via the ERK1/2 pathway and serum response elements [J].
de Jager, T ;
Pelzer, T ;
Müller-Botz, S ;
Imam, A ;
Muck, J ;
Neyses, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :27873-27880
[4]   Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men [J].
Doran, PM ;
Riggs, BL ;
Atkinson, EJ ;
Khosla, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (11) :2118-2125
[5]  
Falkenstein E, 2000, PHARMACOL REV, V52, P513
[6]   Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway [J].
Fitzpatrick, JL ;
Mize, AL ;
Wade, CB ;
Harris, JA ;
Shapiro, RA ;
Dorsa, DM .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) :674-682
[7]   The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death [J].
Grotewold, L ;
Rüther, U .
EMBO JOURNAL, 2002, 21 (05) :966-975
[8]   Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity [J].
Kousteni, S ;
Bellido, T ;
Plotkin, LI ;
O'Brien, CA ;
Bodenner, DL ;
Han, L ;
Han, K ;
DiGregorio, GB ;
Katzenellenbogen, JA ;
Katzenellenbogen, BS ;
Roberson, PK ;
Weinstein, RS ;
Jilka, RL ;
Manolagas, SC .
CELL, 2001, 104 (05) :719-730
[9]  
Kousteni S, 2002, J BONE MINER RES, V17, pS169
[10]   Estrogen receptor pathways to AP-1 [J].
Kushner, PJ ;
Agard, DA ;
Greene, GL ;
Scanlan, TS ;
Shiau, AK ;
Uht, RM ;
Webb, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 74 (05) :311-317